The role of loops B and C in determining the potentiation of GABAA receptors by midazolam.
Ontology highlight
ABSTRACT: Many benzodiazepines are positive allosteric modulators (PAMs) of GABAA receptors that cause sedation, hypnosis, and anxiolysis. Benzodiazepines bind GABAA receptors at the extracellular interface of the ? and ? subunits. Within the ? subunit, the benzodiazepine binding site is defined by three highly conserved structural loops, loops A-C. Although previous mutagenesis studies have identified His102 in Loop A as important for benzodiazepine modulation of GABAA receptors, the functional roles of many of the other conserved residues in loops A-C remain incompletely understood. In this study, we made single mutations in loops A-C of the benzodiazepine binding-site across all six ? subunits. We used whole-cell patch clamp recording to measure the functional effects of these mutations on midazolam potentiation. The results showed that mutating the threonine in loop B and serine in loop C (Thr163 and S206 in human ?1) did not abolish the receptors' responsiveness to midazolam, as the ?1(H102R) mutation did. The loop C mutations exhibited a novel array of ?-isoform specific effects on midazolam potentiation. The ?3(S230I) and ?5(S209I) mutations had the largest effect on midazolam potentiation, increasing the efficacy of midazolam. Novel benzodiazepines targeting loop C may represent a future direction for designing new drugs that specifically alter the activity of ?3- and ?5-containing GABAA receptors.
SUBMITTER: Moody OA
PROVIDER: S-EPMC6234229 | biostudies-literature | 2018 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA